Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BY 4.0iScience

Oncogenic CLDN1 promotes thyroid cancer progression through TAp63-mediated glycolytic switching

Related

  1. FAM50A promotes esophageal squamous cell carcinoma progression via splicing-dependent oncogenic circSDK1- and DUSP22-mediated MAPK/FAK activation.
    Yan Bian, Ye Gao, Xin Chang +7
    Cell discoveryPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCDOAJ
  2. Oncogenic hsa_circ_0000247 Promotes Breast Cancer Malignancy Through hsa‐let‐7i‐5p Sponging‐Mediated HMGA1 Upregulation
    Mingming Qin, Xue Chai, Kai Ye +6
    Cancer MedicinePeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMC
  3. N-WASP deficiency enhances oncogenic KRAS-mediated lung adenocarcinoma progression in mice
    Apoorva Verma, Nanyang Li, Pazhanichamy Kalailingam +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  4. RBM15/IGF2BP1-mediated m 6A methylation of AKR1B10 promotes the progression of cervical squamous cell carcinoma
    义波 陈, 元娜 姜, 前 王 +4
    Journal of Central South University Medical SciencesPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMC
  5. BCAM-AKT2 fusion protein promotes unfolded protein response driven oncogenic signaling in SKOV3 epithelial ovarian cancer cell line
    Hala Khazem, Ravid Solomon Zemler, Liron Vardi David +5
    PLOS OnePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationStatisticsPLOS
BibTeX
@article{zhang2026oncogenic,
  title = {{Oncogenic CLDN1 promotes thyroid cancer progression through TAp63-mediated glycolytic switching}},
  author = {Bowei Zhang and Jinju Wang and Qianxi Zhang and Quanxin Wan},
  journal = {iScience},
  year = {2026},
  month = nov,
  doi = {10.1016/j.isci.2026.117943},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S2589004226033262},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Oncogenic CLDN1 promotes thyroid cancer progression through TAp63-mediated glycolytic switching
AU  - Bowei Zhang
AU  - Jinju Wang
AU  - Qianxi Zhang
AU  - Quanxin Wan
PY  - 2026
DA  - 2026/11/01
JO  - iScience
DO  - 10.1016/j.isci.2026.117943
UR  - https://linkinghub.elsevier.com/retrieve/pii/S2589004226033262
SN  - 2589-0042
ER  -